Public Sector Pension Investment Board (PSP Investments)’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.97M Buy
447,930
+14,683
+3% +$351K 0.03% 562
2025
Q4
$11.6M Sell
433,247
-53,741
-11% -$1.28M 0.04% 407
2025
Q3
$10.4M Buy
486,988
+64,736
+15% +$1.53M 0.04% 432
2025
Q2
$9.11M Buy
422,252
+31,821
+8% +$591K 0.04% 421
2025
Q1
$6.49M Buy
+390,431
New +$7.09M 0.03% 570

Other funds holding ACAD

Public Sector Pension Investment Board (PSP Investments)'s ACAD Position: Q1 2026 in Review

Public Sector Pension Investment Board (PSP Investments) increased its Acadia Pharmaceuticals (ACAD) stake by 3.4% in Q1 2026, buying an estimated $351K and bringing the position to 447,930 shares worth $9.97M. The position accounts for 0.03% of the portfolio, ranked #562.

Public Sector Pension Investment Board (PSP Investments) first reported a position in ACAD in Q1 2025 and has held it in 5 quarters since. The position peaked at $11.6M in Q4 2025. 342 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • Public Sector Pension Investment Board (PSP Investments) held 447,930 shares of Acadia Pharmaceuticals worth $9.97M as of Q1 2026.
  • Public Sector Pension Investment Board (PSP Investments) bought 14,683 Acadia Pharmaceuticals shares in Q1 2026, an estimated $351K.
  • Acadia Pharmaceuticals made up 0.03% of Public Sector Pension Investment Board (PSP Investments)'s portfolio in Q1 2026, its #562 holding.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Acadia Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Public Sector Pension Investment Board (PSP Investments)'s Acadia Pharmaceuticals position peaked at $11.6M in Q4 2025.
  • 342 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q1 2026, filed 13 May 2026.